Nabil Mohie Abdel-Hamid

7PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)Te horakai me ngā kai o te Māori (Māori diet and nutrition)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 20, 2023
The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma.

Nabil M Abdel-Hamid, Sherin M Zakaria, Abeer M Ansary

|Feb 22, 2023
Efficient chemosensitizing and antimetastatic combinations of a naturally occurring trans-ferulic acid with different chemotherapies on an in vitro hepatocellular carcinoma model.

Nabil Mohie Abdel-Hamid, Nadia A ElNakeeb, Fardous F El-Senduny

|Aug 11, 2021
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.

Nabil M Abdel-Hamid, Shimaa A Abass

|Jun 02, 2021
Identification of Chemo and Radio-Resistant Sub-Population of Stem Cells in Human Cervical Cancer HeLa Cells.

Nabil Mohie Abdel-Hamid, Moustafa Fathy, Chika Koike

|Feb 11, 2021
Possible Protective Potency of Argun Nut (Medemia argun - An Ancient Egyptian Palm) against Hepatocellular Carcinoma in Rats.

Nabil Mohie Abdel-Hamid, Sara Gamal Abd Allah, Mohamed K Hassan

Pageof 2